Evoke Pharma Inc (EVOK)
4.35
-0.15
(-3.33%)
USD |
NASDAQ |
Nov 22, 16:00
4.22
-0.13
(-2.99%)
After-Hours: 19:59
Evoke Pharma Total Liabilities (Quarterly): 9.766M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 9.766M |
| June 30, 2024 | 9.471M |
| March 31, 2024 | 8.957M |
| December 31, 2023 | 9.648M |
| September 30, 2023 | 8.727M |
| June 30, 2023 | 8.441M |
| March 31, 2023 | 7.913M |
| December 31, 2022 | 7.767M |
| September 30, 2022 | 7.878M |
| June 30, 2022 | 7.213M |
| March 31, 2022 | 7.092M |
| December 31, 2021 | 7.018M |
| September 30, 2021 | 6.877M |
| June 30, 2021 | 11.59M |
| March 31, 2021 | 11.48M |
| December 31, 2020 | 12.65M |
| September 30, 2020 | 8.674M |
| June 30, 2020 | 8.641M |
| March 31, 2020 | 1.716M |
| December 31, 2019 | 2.015M |
| September 30, 2019 | 2.154M |
| June 30, 2019 | 1.285M |
| March 31, 2019 | 1.287M |
| December 31, 2018 | 1.634M |
| Date | Value |
|---|---|
| September 30, 2018 | 1.611M |
| June 30, 2018 | 1.266M |
| March 31, 2018 | 1.196M |
| December 31, 2017 | 5.776M |
| September 30, 2017 | 8.700M |
| June 30, 2017 | 6.386M |
| March 31, 2017 | 6.904M |
| December 31, 2016 | 5.507M |
| September 30, 2016 | 6.11M |
| June 30, 2016 | 6.163M |
| March 31, 2016 | 6.115M |
| December 31, 2015 | 6.068M |
| September 30, 2015 | 6.375M |
| June 30, 2015 | 6.296M |
| March 31, 2015 | 6.188M |
| December 31, 2014 | 6.044M |
| September 30, 2014 | 1.700M |
| June 30, 2014 | 1.854M |
| March 31, 2014 | 4.116M |
| December 31, 2013 | 3.803M |
| September 30, 2013 | 4.515M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 1.696M |
| December 31, 2012 | 19.78M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.716M
Minimum
Mar 2020
12.65M
Maximum
Dec 2020
8.177M
Average
8.541M
Median
Total Liabilities (Quarterly) Benchmarks
| Repligen Corp | 813.96M |
| Eli Lilly and Co | 61.29B |
| MEI Pharma Inc | 2.872M |
| Revance Therapeutics Inc | 624.59M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.15M |
| Shareholders Equity (Quarterly) | 4.387M |
| Debt to Equity Ratio | 1.140 |
| Current Ratio | 1.437 |